Showing results (31-40 of 170) with videos related to
Sort By:
Pageof 17
Cancer Treatment Reports|April 1, 1983
Phase II clinical evaluation of 4'-epi-doxorubicinP Hurteloup, P Cappelaere, J P Armand, et al.European Journal of Cancer & Clinical Oncology|June 1, 1985
Hormonal steroid receptors in intracranial tumours and their relevance in hormone therapyP Courriere, M Tremoulet, N Eche, et al.Bulletin Du Cancer|January 1, 1990
[Cardiotoxicity of continuous intravenous infusion of 5-fluorouracil: clinical study, prevention and physiopathology. Apropos of 13 cases]M de Forni, R Bugat, F Sorbette, et al.Biochemical and Biophysical Research Communications|July 29, 1988
Accumulation of large VLDL in cyclophosphamide treated rabbits. Relationship with lipoprotein lipase deficiencyA Lespine, N Dousset, B Perret, et al.Cancer Chemotherapy and Pharmacology|January 4, 2001
Stability of commercial solutions of 5-fluorouracil for continuous infusion in an ambulatory pumpA Fournet, V Gilard, M Malet-Martino, et al.Pediatrie|June 1, 1984
[Dyssegmental dwarfism. A new case]J Maisonneuve, J P Armand, J J Louis, et al.European Journal of Cancer (Oxford, England : 1990)|February 23, 2002
Scientific review of EORTC trials: the functioning of the New Treatment Committee and Protocol Review CommitteeC Lardot, W Steward, M Van Glabbeke, et al.Bulletin Du Cancer|April 1, 1993
Anatomic changes in the abdominal cavity during intraperitoneal chemotherapy: prospective study using scintigraphic peritoneographyM de Forni, A Boneu, P Otal, et al.Bulletin Du Cancer|January 1, 1977
[Evaluation of the results of radiotherapy in 14 cases of malignant thymoma. Therapeutic prospects]A Pons, J P Armand, J J Voigt, et al.Cancer Chemotherapy and Pharmacology|January 1, 1989
A new anticancer agent (LY186641) interferes with creatinine assayM M Bonnay, G Recondo, A J Gouyette, et al.Pageof 17